139 related articles for article (PubMed ID: 6259628)
1. Bone uptake of 99mTc-phosphate via labeled plasma protein.
Schümichen C; Seifritz R; Hoffmann G
Nuklearmedizin; 1980 Aug; 19(4):174-7. PubMed ID: 6259628
[TBL] [Abstract][Full Text] [Related]
2. Bone accumulation of 99mTc-labeled leucocytes.
Bagwe BA; Sharma SM
J Nucl Med; 1976 Apr; 17(4):313-6. PubMed ID: 1255260
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
Schümichen C; Walden J; Hoffmann G
Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
Kaye M; Silverton S; Rosenthall L
J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
[TBL] [Abstract][Full Text] [Related]
6. Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals.
Krishnamurthy GT; Huebotter RJ; Tubis M; Blahd WH
AJR Am J Roentgenol; 1976 Feb; 126(2):293-301. PubMed ID: 175699
[TBL] [Abstract][Full Text] [Related]
7. The extraction from the blood of phosphate compounds by canine bone.
Hughes SP; Wahner HW; Kelly PJ; Davies DR
Nuklearmedizin; 1979 Jun; 18(3):137-41. PubMed ID: 228254
[TBL] [Abstract][Full Text] [Related]
8. Binding of technetium-99m to plasma proteins: influence on the distribution of Tc-99m phosphate agents.
Schümichen C; Koch K; Kraus A; Kuhlicke G; Weiler K; Wenn A; Hoffman G
J Nucl Med; 1980 Nov; 21(11):1080-5. PubMed ID: 7431108
[TBL] [Abstract][Full Text] [Related]
9. Complexing of reduced technetium and tin(II) by chelating phosphate compounds. II. In vitro stability of pyrophosphate and ethane-1, hydroxy-1, diphosphonate (EHDP) complexes.
Schümichen C; Hohloch M; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):105-9. PubMed ID: 38437
[TBL] [Abstract][Full Text] [Related]
10. [Investigations on the bone uptake of 99mTc-pyrophosphate, 99mTc-poly-phosphate and radio-strontium (author's transl)].
Büll U; Frey KW
Fortschr Geb Rontgenstr Nuklearmed; 1973 Nov; 119(5):569-77. PubMed ID: 4360989
[No Abstract] [Full Text] [Related]
11. [A comparison of osteotropic radiopharmaceuticals. II. Plasma clearance of 18F and 99mTc-EHDP (author's transl)].
Creutzig H
Rofo; 1975 Oct; 123(4):313-8. PubMed ID: 129388
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of 99mTc-labeled pyrophosphate and polyphosphate in man.
Krishnamurthy GT; Huebotter RJ; Walsh CF; Taylor JR; Kehr MD; Tubis M; Blahd WH
J Nucl Med; 1975 Feb; 16(2):109-15. PubMed ID: 162949
[TBL] [Abstract][Full Text] [Related]
13. Complexing of reduced technetium and tin (II) by chelating phosphate compounds. I. Chemical state of technetium.
Schümichen C; Hohloch H; Schiller A; Pohle W; Hoffmann G
Nuklearmedizin; 1979 May; 18(2):98-104. PubMed ID: 38438
[TBL] [Abstract][Full Text] [Related]
14. The distribution of 99mTc-EHDP in the tissues of the dog and its application in the assessment of fracture healing.
Hughes S
Ann R Coll Surg Engl; 1977 Jul; 59(4):322-7. PubMed ID: 879636
[TBL] [Abstract][Full Text] [Related]
15. [Comparative investigations of osteotropic isotopes. i animal experiments on the uptake of 18f, 85sr and 99mtc-ehdp (author's transl)].
Creutzig H; Creutzig A; Gerdts KG; Greif E; Eckhardt W
Rofo; 1975 Aug; 123(2):137-43. PubMed ID: 129373
[TBL] [Abstract][Full Text] [Related]
16. Skeletal uptake of 99mTc-diphosphonate in relation to local bone blood flow.
Siegel BA; Donovan RL; Alderson PO; Mack GR
Radiology; 1976 Jul; 120(1):121-3. PubMed ID: 935433
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the bone seeking properties of short-chained 99mTc-Sn-polyphosphates.
Schümichen C; Nakken KF
Nucl Med (Stuttg); 1974 Aug; 13(2):139-43. PubMed ID: 4373697
[No Abstract] [Full Text] [Related]
18. [Concentration of 99mTc-tin-phosphate complexes in soft tissues].
Büll U; von Lieven H; Leisner B
Nucl Med (Stuttg); 1975 Jun; 14(2):91-105. PubMed ID: 170592
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacologic and biokinetic data on the use of 99mTc-labeled phosphate compounds].
Kriegel H
Med Welt; 1977 Jan; 28(2):55-60. PubMed ID: 840011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
